Filter
131
Filtered Results: 131
Text search:
Biosafety
and
biosecurity
Featured
Recommendations
15
New Publications
33
Language
Document type
No document type
47
Guidelines
22
Studies & Reports
21
Manuals
20
Strategic & Response Plan
12
Training Material
6
Situation Updates
2
Resource Platforms
1
Countries / Regions
Africa
13
Ukraine
8
Nigeria
6
India
6
Kenya
6
Sierra Leone
5
Latin America and the Carribbean
5
Global
4
Uganda
3
East and Southern Africa
3
West and Central Africa
3
Middle East and North Africa
3
South–East Asia Region
3
Nepal
2
Syria
2
Namibia
2
Western Pacific Region
2
Moldova
2
Guinea
1
Liberia
1
Guinea-Bissau
1
Ethiopia
1
Ghana
1
Philippines
1
Pakistan
1
Afghanistan
1
Zambia
1
Indonesia
1
South Africa
1
Bangladesh
1
Malawi
1
Mozambique
1
Brazil
1
North Macedonia
1
Hungary
1
Angola
1
Western and Central Europe
1
Poland
1
Eastern Europe
1
Bulgaria
1
Romania
1
Slovakia
1
North America
1
Authors & Publishers
Publication Years
Category
Countries
56
Pharmacy & Technologies
22
Public Health
9
Key Resources
5
Clinical Guidelines
3
Toolboxes
Rapid Response
32
COVID-19
24
AMR
13
Ebola
10
Conflict
10
TB
6
Planetary Health
5
HIV
4
Polio
2
Specific Hazards
2
Pharmacy
2
Health Financing Toolbox
2
Cholera
1
Global Health Education
1
Biosafety involves the implementation of containment principles, technologies and practices to prevent unintentional exposure to biological agents. Biosec... involves the protection, control and accountability of biological materials and information related to these materials and dualuse research, to prevent their unauthorized access, loss, theft, misuse, diversion or intentional release.
Biosafety involves the implementation of containment principles, technologies and practices to prevent unintentional exposure to biological agents. Biosec... involves the protection, control and accountability of biological materials and information related to these materials and dualuse research, to prevent their unauthorized access, loss, theft, misuse, diversion or intentional release.
The WHO BioHub Biosafety & Biosecurity: criteria and operational modalities sets out the requirements to which laboratories wishing to receive biol...
Biosafety involves the implementation of containment principles, technologies and practices to prevent unintentional exposure to biological agents. Biosec... involves the protection, control and accountability of biological materials and information related to these materials and dualuse research, to prevent their unauthorized access, loss, theft, misuse, diversion or intentional release.
Laboratory biosafety manual
recommended
4th edition
The WHO Laboratory Biosafety Manual (LBM) has been in broad use at all levels of clinical and public health laboratories, and other bi...
Biosafety involves the implementation of containment principles, technologies and practices to prevent unintentional exposure to biological agents. Biosec... involves the protection, control and accountability of biological materials and information related to these materials and dualuse research, to prevent their unauthorized access, loss, theft, misuse, diversion or intentional release.
he Framework sets the requirements for facilities handling High Consequence Agents and Toxins (HCATs) and guides the implementation of laboratory biosafet... and biosecurity practices associated with the design, commissioning, routine operation safe and secure biocontainment laboratories.
The Africa Centres for Disease Control and Prevention (Africa CDC) Biosafety and Biosecurity Ini...
The Africa Centres for Disease Control and Prevention (Africa CDC) Biosafety and Biosecurity Ini...
Biosafety involves the implementation of containment principles, technologies and practices to prevent unintentional exposure to biological agents. Biosec... involves the protection, control and accountability of biological materials and information related to these materials and dualuse research, to prevent their unauthorized access, loss, theft, misuse, diversion or intentional release.
Biosafety involves the implementation of containment principles, technologies and practices to prevent unintentional exposure to biological agents. Biosec... involves the protection, control and accountability of biological materials and information related to these materials and dualuse research, to prevent their unauthorized access, loss, theft, misuse, diversion or intentional release.
The intent of these guidelines is to develop a holistic, coordinated, proactive and technology driven strategy for management of biological disasters through a culture of prevention, mitigation and ...
The Global guidance framework for the responsible use of the life sciences: mitigating biorisks and governing dual-use research (the framework) aims to provide values and principles, tools ... mechanisms to support Member States and key stakeholders to mitigate and prevent biorisks and govern dual-use research.
The framework adopts the One health approach and focuses on the role that responsible life sciences research can play in preventing and mitigating risks caused by accidents, inadvertent or deliberate misuse with the intention to cause harm to humans, nonhuman animals, plants and agriculture, and the environment.
Laboratory Biossafety Manual
Esta quarta edição do manual se baseia no esquema de avaliação de risco apresentado na terceira edição. Uma avaliação completa, baseada em evidências e transparente dos riscos permite que as medidas de segurança sejam equilibradas com o risco real de trabalhar com agentes biológicos, caso...
Mission report: June 11-20, 2017
Laboratory biosafety guidance related to coronavirus disease (COVID-19): Interim guidance, 28 January 2021
recommended
The latest update (28 January 2021) includes the following addition and revision:
biosafety aspects for working with antigen-detecting rapid diagnostic test;
handling new variants of SAR...
Antimicrobial resistance (AMR) has emerged as a leading cause of death in the African region, surpassing fatalities from malaria, HIV, and TB. In response to this critical threat, the region has adopted the AMR Global Action Plan ... the African Union Framework for Antimicrobial Resistance Control 2020 – 2025, which is tailored to meet the specific needs of African nations through a coordinated approach. While most countries in the region have developed and prioritized National Action Plans (NAPs) to tackle AMR, the overall response remains inadequate given the magnitude of the threat, which endangers human, animal, environmental, aquatic, and plant health.
Africa bears a significant burden of infectious diseases, accounting for approximately 95% of malaria deaths, 70% of people living with HIV, and 25% of TB deaths globally. In 2019, AMR was linked to approximately 55,000 deaths from HIV, 30,000 from malaria, and 255,000 overall. Major drivers of AMR in the region include the overuse and misuse of antimicrobials in human and food systems, migration, suboptimal vaccination rates, and environmental contamination from hospital and pharmaceutical effluents. Additionally, there is a lack of access to quality-assured antimicrobials and diagnostics, compounded by inadequate knowledge about AMR. Unlike high-income countries, where indiscriminate antimicrobial use is the primary factor driving AMR, African countries face additional challenges, including a lack of access to clean and safe water, poor Water, Sanitation, and Hygiene (WASH) programs, inadequate infection prevention measures, and suboptimal vaccinations for preventable diseases. One in three hospitals in the region lacks clean, safe running water, and one in eight people defecate openly due to inadequate sanitation. Investments in WASH, infection prevention, and biosecurity could save approximately 700,000 lives annually.
Addressing AMR in Africa requires a comprehensive, multi-sectoral approach involving the entire society. Sustainable access to antimicrobials, including antibiotics, vaccines, and therapeutics, is crucial, as lack of access leads to more morbidity and mortality than AMR itself. Support for the region should focus on preventing infections, strengthening health and food systems, developing human resources, ensuring sustainable access to diagnostics and therapeutics, and investing in laboratory infrastructure to support surveillance and data generation.
